These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 5635365

  • 1. Sparing action of uridine on the activity of arabinosylcytosine with normal and leukemic mice.
    Saslaw LD, Grindey GB, Kline I, Waravdekar VS.
    Cancer Res; 1968 Jan; 28(1):11-20. PubMed ID: 5635365
    [No Abstract] [Full Text] [Related]

  • 2. Effects of uracil derivatives on phosphorylation of arabinosylcytosine.
    Grindey GB, Saslaw LD, Waravdekar VS.
    Mol Pharmacol; 1968 Jan; 4(1):96-103. PubMed ID: 5640783
    [No Abstract] [Full Text] [Related]

  • 3. Enhancement by tetrahydrouridine of 1-beta-D-arabinofuranosylcytosine (cytarabine) oral activity in L1210 leukemic mice.
    Neil GL, Moxley TE, Manak RC.
    Cancer Res; 1970 Aug; 30(8):2166-72. PubMed ID: 4990003
    [No Abstract] [Full Text] [Related]

  • 4. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR, Campbell J, Rustum YM.
    Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
    [Abstract] [Full Text] [Related]

  • 5. Analogs of 1-beta-D-arabinofuranosylcytosine. Studies on mechanisms of action in Burkitt's cell culture and mouse leukemia, and in vitro deamination studies.
    Dollinger MR, Burchenal JH, Kreis W, Fox JJ.
    Biochem Pharmacol; 1967 Apr; 16(4):689-706. PubMed ID: 6033789
    [No Abstract] [Full Text] [Related]

  • 6. Effect of combined therapy with cytosine arabinoside (NSC-63878) and l,3-bis-(2-chloroethyl)-1-nitrosourea (NSC-409962) on sarcoma 180 and L1210 in vivo.
    Mizuno NS, Humphrey EW.
    Cancer Chemother Rep; 1969 Sep; 53(4):215-21. PubMed ID: 5384462
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibitory potency of 5-benzyluracil, 5-phenylcytosine and 5-phenylpyrimidin-2-one nucleosides against uridine phosphorylase from mouse leukemic L1210 cells.
    Votruba I, Krecmerová M, Hrebabecký H, Holý A.
    Nucleosides Nucleotides; 1999 Sep; 18(11-12):2551-64. PubMed ID: 10639754
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combination chemotherapy with cytosine arabinoside, L-asparaginase, and 6-azauridine for transplantable murine leukemias.
    Avery TL, Roberts D.
    Cancer Res; 1973 Apr; 33(4):791-9. PubMed ID: 4696479
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Influence of mitotic cycle inhibitors on the antileukemic activity of cytosine arabinoside (NSC-63878) in mice bearing leukemia L1210.
    Vadlamudi S, Goldin A.
    Cancer Chemother Rep; 1971 Dec; 55(5):547-55. PubMed ID: 5159846
    [No Abstract] [Full Text] [Related]

  • 15. Immunosuppressive activity of methotrexate and arabinosyl cytosine in mice bearing L1210 leukaemia.
    Baldini L, Brambilla G, Cavanna M, Parodi S.
    Br J Pharmacol; 1968 Nov; 34(3):674P-676P. PubMed ID: 5726804
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Thymine starvation by inhibition of uptake and synthesis of thymine-compounds in Tetrahymena.
    Zeuthen E.
    Exp Cell Res; 1968 Apr; 50(1):37-46. PubMed ID: 5650862
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.